Nate Bard serves as CEO of Triumph Orthopedics, Shore Capital’s orthopedic services platform investment, and as a Board Member for Column Health, Shore Capital's second medication-assisted treatment platform investment.
Most recently, Nate previously lead ATI Physical Therapy’s (“ATI”) growth function, serving as its Chief Growth Officer. In this role, he was responsible for sales, marketing, mergers, acquisitions, and new clinic growth and openings. Nate joined ATI in 2014, bringing a background in private equity and investment banking experience. Originally from Michigan, Bard is a graduate of the University of Notre Dame with a degree in Finance. With a combination of strategic and financial expertise, Nate has helped ATI expand its acquisition capabilities with an analytical approach to decision making.